Related Experiment Videos
Nifedipine as a therapeutic modality for Raynaud's phenomenon
Arthritis and Rheumatism
|October 1, 1983
Summary
Nifedipine significantly reduced Raynaud
Area of Science:
- Cardiovascular Research
- Pharmacology
- Vascular Biology
Background:
- Raynaud's phenomenon is a condition causing vasospasm in extremities.
- Digital ulcers are a severe complication of Raynaud's phenomenon.
Purpose of the Study:
- To evaluate the efficacy of nifedipine in treating Raynaud's phenomenon.
- To assess nifedipine's effect on digital blood flow and ulcer healing.
Main Methods:
- Double-blind, placebo-controlled crossover study.
- Eight patients with Raynaud's phenomenon participated.
- Finger plethysmography was used to measure blood flow before and after sublingual nifedipine.
Main Results:
- All patients reported fewer and less severe Raynaud's attacks with nifedipine.
- Four out of five patients experienced digital ulcer healing.
- Sublingual nifedipine increased total finger blood flow in most patients.
Conclusions:
- Nifedipine shows promise as a treatment for Raynaud's phenomenon.
- The drug may help manage digital vasospasm and improve ulcer healing.
- Further research is warranted to confirm these preliminary findings.